USFDA rejection of Covaxin not to impact India’s Covid-19 vaccination drive

0
22

Their decision has no bearing on our programme, VK Paul, member, health, Niti Aayog, said at a media briefing on Friday. The country’s regulators are satisfied and have approved the vaccine with lot of data on safety and Phase-III trials, Paul said.